Literature DB >> 3753748

Nucleotide sequence of chicken c-myb complementary DNA and implications for myb oncogene activation.

D Rosson, E P Reddy.   

Abstract

Avian myeloblastosis virus (AMV), like other acute transforming viruses, arose by recombination between its helper virus and host cellular sequences. The latter sequences, termed v-myb, are responsible for the oncogenic properties of the virus. AMV causes acute myeloblastic leukaemia in chickens and transforms a specific class of haematopoietic cells in vitro, but does not induce morphological transformation of cultured fibroblasts, suggesting that only a restricted target-cell population is responsive to its transforming gene product. The normal cellular counterpart of v-myb, c-myb, is highly conserved and is present in all vertebrate and some invertebrate species examined. DNA rearrangements and altered expression of the myb oncogene have been reported in mouse lymphoid tumours and human myeloid and colon tumours. The mechanism of activation of the cellular proto-oncogenes is thought to involve the structural alteration of the coding regions that result in either the synthesis of an altered gene product or the enhanced expression of a proto-oncogene caused by alterations in its regulatory elements. To distinguish between these two mechanisms, we have cloned and sequenced the chicken c-myb complementary DNA and compared it with that of v-myb sequences. We demonstrate that during the transduction of the cellular sequences and/or viral passage a substantial portion of the coding region of the c-myb gene has been lost from both the 5' and 3' ends, resulting in the generation of a truncated gene product that mediates the transforming function of the virus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3753748     DOI: 10.1038/319604a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  50 in total

1.  Role of tryptophan repeats and flanking amino acids in Myb-DNA interactions.

Authors:  P Saikumar; R Murali; E P Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Characterization of the v-myb DNA binding domain.

Authors:  T Oehler; H Arnold; H Biedenkapp; K H Klempnauer
Journal:  Nucleic Acids Res       Date:  1990-04-11       Impact factor: 16.971

3.  A potential splicing factor is encoded by the opposite strand of the trans-spliced c-myb exon.

Authors:  M Vellard; A Sureau; J Soret; C Martinerie; B Perbal
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

4.  Protein truncation is required for the activation of the c-myb proto-oncogene.

Authors:  F A Grässer; T Graf; J S Lipsick
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

5.  Acute myeloid leukemia induction by amphotropic murine retrovirus (4070A): clonal integrations involve c-myb in some but not all leukemias.

Authors:  L Wolff; R Koller; W Davidson
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

6.  Myb and Ets proteins cooperate in transcriptional activation of the mim-1 promoter.

Authors:  H Dudek; R V Tantravahi; V N Rao; E S Reddy; E P Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

7.  Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1.

Authors:  H Hirai; C J Sherr
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

8.  v-myb blocks granulocyte colony-stimulating factor-induced myeloid cell differentiation but not proliferation.

Authors:  G Patel; B Kreider; G Rovera; E P Reddy
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

9.  Multiple genes are transcribed in Hordeum vulgare and Zea mays that carry the DNA binding domain of the myb oncoproteins.

Authors:  A Marocco; M Wissenbach; D Becker; J Paz-Ares; H Saedler; F Salamini; W Rohde
Journal:  Mol Gen Genet       Date:  1989-04

10.  Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene.

Authors:  H Sakura; C Kanei-Ishii; T Nagase; H Nakagoshi; T J Gonda; S Ishii
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.